Dr. Mark Pe

Dr. Mark Pe
A native Southern Californian, Dr. Pe earned his bachelor's degree in microbiology and molecular genetics and master's degree in physiological science at the University of California, Los Angeles in 1999. He received his medical degree at Sidney Kimmel Medical College in Philadelphia in 2004. After medical school, Dr. Pe completed his residency in general surgery and urology at Thomas Jefferson University Hospital in Philadelphia in 2010. During his residency, he trained under Dr. Demetrius Bagley, a pioneer and a leading authority of endourology and kidney stone disease. Dr. Pe is a member of many professional organizations such as the American Urologic Association and the San Diego Urologic Society. He has also authored numerous abstracts, peer-reviewed publications, and book chapters, and has presented his findings at both national and international medical conferences. Dr. Pe is an advocate of minimally invasive treatment for both benign and malignant urologic diseases. He has trained on the da Vinci surgical robot and is part of the Scripps Minimally Invasive Robotic Surgery team. Dr. Pe has a particular interest in endoscopic treatments of the prostate for BPH and stone disease. He has taught courses for physician colleagues regarding treatment for BPH and stones, and has established centers of excellence for various BPH treatments. He maintains one of the busiest practices in San Diego County and serves as a referral source for more complicated cases.
Medical School:

Sidney Kimmel Medical College


Thomas Jefferson University Hospital

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only